Article Text

Download PDFPDF

Original article
Quality improvement initiative using transcutaneous bilirubin nomogram to decrease serum bilirubin sampling in low-risk babies
  1. Muhammad Hussain Shah1,
  2. Shabina Ariff1,
  3. Syed Rehan Ali2,
  4. Rayaan Asad Chaudhry1,
  5. Maryam Pyar Ali Lakhdir3,
  6. Fatima Qaiser4,
  7. Simon Demas1,
  8. Ali Shabbir Hussain1
  1. 1 Department of Paediatrics and Child Health, The Aga Khan University, Karachi, Pakistan
  2. 2 The Indus Hospital, Karachi, Pakistan
  3. 3 Department of Community Health Sciences, The Aga Khan University, Karachi, Pakistan
  4. 4 Department of Pediatrics, Dow University of Health Sciences, Karachi, Pakistan
  1. Correspondence to Dr Ali Shabbir Hussain, The Aga Khan University; ali.hussain{at}aku.edu

Abstract

Background Screening for neonatal hyperbilirubinaemia in the postnatal ward has traditionally been performed using serum bilirubin sampling, but this has significant drawbacks such as risk of infection and slower reporting time.

Objective We aimed to assess the impact of introducing transcutaneous bilirubin (TcBR) testing using TcBR nomogram on the number of serum bilirubin samples sent.

Methods A before-and-after study was performed following the introduction of a protocol integrating the use of the Dragger JM-105 transcutaneous bilirubinometer in the postnatal ward. Only babies born at ≥37 weeks of gestation, weighing ≥2500 g who presented with jaundice after the first 24 hours and within the first 7 days of life were included in the study. The number of total serum bilirubin samples (TSBRs) sent were compared for the 6-month periods before and after (a total of 12 months) implementation of the new protocol.

Results In the pre-implementation phase, a total of 882 (49%) out of 1815 babies had at least one serum bilirubin sample taken as opposed to a total of 236 (17%) out of 1394 babies in the post-implementation phase. The odds of performing TSBRs at least one time among babies in post-implementation phase were 79% lower than in pre-implementation phase (OR 0.21, 95% CI 0.18 to 0.25). We also estimated a significant cost saving of approximately US$1800 over a period of 6 months

Conclusion TcBR testing used in conjunction with our proposed nomogram significantly reduces the need for serum bilirubin sampling.

  • jaundice
  • neonate
  • TcB nomogram

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors SRA, ASH and MSA planned, conducted the study and reviewed the manuscript. RA, MA, ASH helped in analysis and wrote the initial draft. FQ and MHS helped in conducting, analysis and manuscript writing. SD helped in conducting the study. All authors contributed equally in finalising the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Ethics approval This study was approved by the AKU ethical review committee ERC number :4742-ped-ERC-17.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Not required.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.